167 related articles for article (PubMed ID: 22177242)
1. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Immunohistochemical Study of Epithelial Membrane Antigen and NHERF1/EBP50 in the Diagnosis of Ependymomas.
Nambirajan A; Sharma MC; Rajeshwari M; Kakkar A; Suri V; Sarkar C
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):71-78. PubMed ID: 27753657
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin is a potential marker for the diagnosis of ependymoma: a comparative study with epithelial membrane antigen (EMA).
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2009; 28(5):373-8. PubMed ID: 19788053
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
[TBL] [Abstract][Full Text] [Related]
6. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of ependymal neoplasms: histological subtypes and glial and epithelial characteristics.
Kaneko Y; Takeshita I; Matsushima T; Iwaki T; Tashima T; Fukui M
Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):97-103. PubMed ID: 1695040
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study for choroid plexus papillomas and ependymomas].
Kunishio K; Shiraishi T; Mishima N; Matsumi N; Satoh T; Matsumoto K; Furuta T; Nishimoto A; Taguchi K
Neurol Med Chir (Tokyo); 1991 Dec; 31(13):859-66. PubMed ID: 1726244
[TBL] [Abstract][Full Text] [Related]
9. Epithelial differentiation and proliferative potential in spinal ependymomas.
Takeuchi H; Kubota T; Sato K; Llena JF; Hirano A
J Neurooncol; 2002 May; 58(1):13-9. PubMed ID: 12160136
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclo-oxygenase-2 in ependymal tumors.
Roma AA; Prayson RA
Neuropathology; 2006 Oct; 26(5):422-8. PubMed ID: 17080719
[TBL] [Abstract][Full Text] [Related]
11. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of CD99 and EMA expression in ependymomas.
Mahfouz S; Aziz AA; Gabal SM; el-Sheikh S
Medscape J Med; 2008 Feb; 10(2):41. PubMed ID: 18382710
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors.
Ogino S; Kubo S; Abdul-Karim FW; Cohen ML
Pediatr Dev Pathol; 2001; 4(1):23-31. PubMed ID: 11200487
[TBL] [Abstract][Full Text] [Related]
14. SOX10 and Olig2 as negative markers for the diagnosis of ependymomas: An immunohistochemical study of 98 glial tumors.
Švajdler M; Rychlý B; Mezencev R; Fröhlichová L; Bednárová A; Pataky F; Daum O
Histol Histopathol; 2016 Jan; 31(1):95-102. PubMed ID: 26287936
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors.
Figarella-Branger D; Lepidi H; Poncet C; Gambarelli D; Bianco N; Rougon G; Pellissier JF
Acta Neuropathol; 1995; 89(3):248-57. PubMed ID: 7754745
[TBL] [Abstract][Full Text] [Related]
16. Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas.
Parker JR; Armstrong DL; Strother D; Rudman DM; Dauser RC; Laurent JP; Deyd J; Rouah PE
J Child Neurol; 2001 Aug; 16(8):548-52. PubMed ID: 11510923
[TBL] [Abstract][Full Text] [Related]
17. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
18. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical markers for prognosis of ependymal neoplasms.
Korshunov A; Golanov A; Timirgaz V
J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
[TBL] [Abstract][Full Text] [Related]
20. Distribution of epithelial membrane antigen in normal and neoplastic human ependyma.
Uematsu Y; Rojas-Corona RR; Llena JF; Hirano A
Acta Neuropathol; 1989; 78(3):325-8. PubMed ID: 2763805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]